Question 1

What is the analyst consensus rating for NVO?

Accepted Answer

The analyst consensus rating for NVO is "Hold" based on 4 analyst recommendations.

Question 2

What is the average price target for NVO?

Accepted Answer

The average 12-month price target for NVO is $50.00, representing an upside of 1.3% from the current price of $49.37.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Dec 8, 2025	John Eade	Argus Research	Downgrades	Hold	-
Nov 28, 2025	James Quigley	Goldman Sachs	Maintains	Strong Buy	$60.00 → $54.00 -6.00 (-10.0%)
Nov 25, 2025	Evan David Seigerman	BMO Capital	Maintains	Hold	$50.00 → $46.00 -4.00 (-8.0%)
Nov 24, 2025	Rajesh Kumar	HSBC	Downgrades	Hold	-

Novo Nordisk A/S (NVO) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest NVO Analyst Ratings & Recommendations